Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275).
作者:
主题词
抗肿瘤药(Antineoplastic Agents);人类(Humans);男(雄)性(Male);肿瘤细胞, 循环(Neoplastic Cells, Circulating);前瞻性研究(Prospective Studies);前列腺特异抗原(Prostate-Specific Antigen);受体, 雄激素(Receptors, Androgen);治疗结果(Treatment Outcome)
DOI
10.1007/s12032-022-01756-2
PMID
35687207
发布时间
2022-06-14
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文